DS
PRME icon

DRW Securities’s Prime Medicine PRME Stock Holding History

DRW Securities’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$48.4K Sell
13,106
-27,858
-68% -$92.5K ﹤0.01% 896
2026
Q1 		$143K Buy
+40,964
New +$156K ﹤0.01% 1159

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

DRW Securities's PRME Position: Q2 2026 in Review

DRW Securities reduced its Prime Medicine (PRME) stake by 68% in Q2 2026, selling an estimated $92.5K and leaving 13,106 shares worth $48.4K. The position accounts for ﹤0.01% of the portfolio, ranked #896.

DRW Securities first reported a position in PRME in Q1 2026 and has held it in 2 quarters since. The position peaked at $143K in Q1 2026. 187 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • DRW Securities held 13,106 shares of Prime Medicine worth $48.4K as of Q2 2026.
  • DRW Securities sold 27,858 Prime Medicine shares in Q2 2026, an estimated $92.5K.
  • Prime Medicine made up ﹤0.01% of DRW Securities's portfolio in Q2 2026, its #896 holding.
  • DRW Securities first reported a position in Prime Medicine in Q1 2026 and has held it in 2 quarters since.
  • DRW Securities's Prime Medicine position peaked at $143K in Q1 2026.
  • 187 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.